These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 17154368

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Erosion of microbicide formulation coating layers: effects of contact and shearing with vaginal fluid or semen.
    Geonnotti AR, Peters JJ, Katz DF.
    J Pharm Sci; 2005 Aug; 94(8):1705-12. PubMed ID: 15986472
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?
    das Neves J, Amiji M, Sarmento B.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011 Aug; 3(4):389-99. PubMed ID: 21506290
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Layer-by-Layer Engineered Microbicide Drug Delivery System Targeting HIV-1 gp120: Physicochemical and Biological Properties.
    Coulibaly FS, Ezoulin MJM, Purohit SS, Ayon NJ, Oyler NA, Youan BC.
    Mol Pharm; 2017 Oct 02; 14(10):3512-3527. PubMed ID: 28830144
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development of pH-sensitive vaginal films based on methacrylate copolymers for topical HIV-1 pre-exposure prophylaxis.
    Notario-Pérez F, Galante J, Martín-Illana A, Cazorla-Luna R, Sarmento B, Ruiz-Caro R, das Neves J, Veiga MD.
    Acta Biomater; 2021 Feb 02; 121():316-327. PubMed ID: 33333257
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials.
    Tien D, Schnaare RL, Kang F, Cohl G, McCormick TJ, Moench TR, Doncel G, Watson K, Buckheit RW, Lewis MG, Schwartz J, Douville K, Romano JW.
    AIDS Res Hum Retroviruses; 2005 Oct 02; 21(10):845-53. PubMed ID: 16225411
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vaginal gel formulation based on theaflavin derivatives as a microbicide to prevent HIV sexual transmission.
    Yang J, Li L, Jin H, Tan S, Qiu J, Yang L, Ding Y, Jiang ZH, Jiang S, Liu S.
    AIDS Res Hum Retroviruses; 2012 Nov 02; 28(11):1498-508. PubMed ID: 22867271
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Liposomal gel with chloramphenicol: characterisation and in vitro release.
    Pavelić Z, Skalko-Basnet N, Jalsenjak I.
    Acta Pharm; 2004 Dec 02; 54(4):319-30. PubMed ID: 15634615
    [Abstract] [Full Text] [Related]

  • 18. Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery.
    Kieweg SL, Katz DF.
    J Biomech Eng; 2006 Aug 02; 128(4):540-53. PubMed ID: 16813445
    [Abstract] [Full Text] [Related]

  • 19. pH-sensitive dual-preventive siRNA-based nanomicrobicide reactivates autophagy and inhibits HIV infection in vaginal CD4+ cells.
    Yang S, Chen Y, Gu J, Harris A, Su RC, Ho EA.
    J Control Release; 2024 Feb 02; 366():849-863. PubMed ID: 38176469
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.